EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence-assisted cytology improves diagnostic consistency and accuracy in cervical cancer screening: A multicenter crossover study

Xiangli Li, Wenjing Zhang, Hong Chen, Anqi Huang, Ju Jin, Daohong Li, Xiaomei Wang, Shiqiao Zhang, Haimiao Xu, Aixia Hu, Mulan Jin

Cytojournal · 30.10.2026 · 23 · 72

DOI: 10.25259/cytojournal_50_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytojournal, online erschienen am 30.10.2026. Verfasst von Xiangli Li und 10 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The effective prevention and control of cervical cancer (CC) depend on high-quality screening. However, traditional cytology interpretation faces challenges such as strong subjectivity, significant inter-observer variability, and a shortage of cytopathologists in primary care settings. The distribution of high-quality medical resources in China is highly uneven between urban and rural areas. Artificial intelligence (AI)-assisted cytology offers a new approach to enhance screening efficacy. This study evaluated the diagnostic performance of a deep learning-based AI-assisted cytology system in a multicenter clinical environment in China, comparing its utility as a standalone tool and in a collaborative model with cytopathologists. Materials and Methods: This was a multicenter, crossover study enrolling a total of 769 outpatient liquid-based cytology samples obtained from three participating hospitals. Using a crossover design, two junior-to-mid-level cytopathologists from primary hospitals performed independent diagnoses and AI-assisted diagnoses (following an AI preliminary screening combined with cytopathologist verification), which were compared with AI-alone diagnoses. Using an expert cytology panel diagnosis as the cytological reference standard, sensitivity (Se), specificity (Sp), overall accuracy, positive predictive value (PPV) negative predictive value, and false-positive rates/false-negative rates and the area under the receiver operating characteristic curve (AUC) were calculated and compared for each modality at the atypical squamous cells of undetermined significance (ASC-US+), low-grade squamous intraepithelial lesions (LSIL+), and high-grade squamous intraepithelial lesions (HSIL+) thresholds.

Results

The study found that the independent diagnostic Se of the primary cytopathologists was insufficient (LSIL+: 46.0% (95% confidence interval [CI]: 0.359–0.564)–50.6% (95% CI: 0.403–0.608); HSIL+: 36.6% (95% CI: 0.236–0.519)–46.3% (95% CI: 0.321–0.613), indicating a high risk of missed diagnoses. AI-alone diagnosis showed high Se (ASC-US+: 92.9% [95% CI: 0.877–0.960]) but a relatively lower PPV (72.0% [95% CI: 0.654–0.778]). AI-assisted diagnostic model achieved a favorable balance. Across all diagnostic thresholds, the AI-assisted modality significantly outperformed cytopathologist-alone diagnosis. At the ASC-US+ threshold, AI-alone Se was 92.9% (95% CI: 0.877–0.960) with a Sp of 90.9% (95% CI: 0.883–0.929), whereas the sensitivities of the two primary cytopathologists alone were 68.4% (95% CI: 0.607–0.752) and 81.3% (95% CI: 0.744–0.866), respectively. With AI assistance, primary cytopathologist Se increased to 92.3% (95% CI: 0.870–0.955)–94.2% (95% CI: 0.893–0.969), and Sp reached 94.6% (95% CI: 0.925–0.961)–96.9% (95% CI: 0.952–0.980). At the LSIL+ and HSIL+ thresholds, where cytopathologist-alone sensitivities were low (LSIL+: 46.0% [95% CI: 0.359–0.564]–50.6% [95% CI: 0.403–0.608]; HSIL+: 36.6% [95% CI: 0.236–0.519]–46.3% [95% CI: 0.321–0.613]), AI assistance improved them to 80.5% (95% CI: 0.709–0.874) and 73.2% (95% CI: 0.581–0.843)–75.6% (95% CI: 0.607–0.862), respectively, with Sp exceeding 97.0% in both cases. Receiver operating characteristic curve analysis confirmed that the AUC for AI-assisted diagnosis (0.938 [95% CI: 0.911–0.965]–0.971 [95% CI: 0.946–0.996]) was significantly higher than that for cytopathologist-alone diagnosis (0.791 [95% CI: 0.746–0.836]–0.868 [95% CI: 0.819–0.918]).

Conclusion

In this exploratory study, the AI-assisted cytology system may help reduce the experience gap for primary cytopathologists in primary hospitals, substantially improving the Se and Sp of cervical cytology interpretation. The AI-assisted diagnostic model is an effective strategy for achieving standardized, high-quality CC screening, particularly for promoting homogeneous services in regions with uneven healthcare resources.

Zitieren

APA

Li, X., Zhang, W., Chen, H., Huang, A., Jin, J., Li, D., Wang, X., Zhang, S., Xu, H., Hu, A., & Jin, M. (2026). Artificial intelligence-assisted cytology improves diagnostic consistency and accuracy in cervical cancer screening: A multicenter crossover study. Cytojournal, 23, 72. https://doi.org/10.25259/cytojournal_50_2026

Vancouver

Li X, Zhang W, Chen H, Huang A, Jin J, Li D, et al. Artificial intelligence-assisted cytology improves diagnostic consistency and accuracy in cervical cancer screening: A multicenter crossover study. Cytojournal. 2026;23:72. doi:10.25259/cytojournal_50_2026

BibTeX
@article{Li2026,
  author = {Li, Xiangli and Zhang, Wenjing and Chen, Hong and Huang, Anqi and Jin, Ju and Li, Daohong and Wang, Xiaomei and Zhang, Shiqiao and Xu, Haimiao and Hu, Aixia and Jin, Mulan},
  title = {Artificial intelligence-assisted cytology improves diagnostic consistency and accuracy in cervical cancer screening: A multicenter crossover study},
  journal = {Cytojournal},
  year = {2026},
  volume = {23},
  pages = {72},
  doi = {10.25259/cytojournal_50_2026}
}
Kostenlos starten →